What is INDOSE?
INDOSE is pioneering the future of cannabis consumption with its innovative real-time, metered precise dosage vaporizer. Co-founded by industry veterans Benzi Ronen and brothers Ari and Dani Freeman, the company has a proven track record of product launches and global retail distribution, raising over $100 million in prior financing. Their technology addresses a critical need for controlled and accurate dosing in the cannabis market.
How much funding has INDOSE raised?
INDOSE has raised a total of $3.6M across 2 funding rounds:
Series A
$3.5M
Debt
$145K
Series A (2019): $3.5M with participation from Casa Verde Capital
Debt (2021): $145K led by PPP
Key Investors in INDOSE
Casa Verde Capital
Casa Verde Capital is a leading venture capital firm specializing in the cannabis industry, investing in scalable businesses that address long-term market needs.
PPP
Public-Private Partnership
Undisclosed investor
Undisclosed investor participating in the funding round.
What's next for INDOSE?
With the recent major strategic investment and substantial enterprise-level funding, INDOSE is poised for significant expansion. This capital infusion will likely fuel further product development, market penetration, and strategic partnerships within the cannabis ecosystem. The company's focus on precise dosage technology positions it for leadership in both medical and recreational cannabis markets.
See full INDOSE company page
